SelectQuote Q3 FY2025 – Revenue Up, Net Income Surges, EBITDA Down

By Tamara Parker • Monday, May 12 10:13 • Permanent Link

SelectQuote, Inc. has reported its financial results for the third quarter of fiscal year 2025, and the figures reveal notable changes compared to the same period in fiscal year 2024.

Consolidated revenue for the third quarter of fiscal year 2025 stood at $408.2 million, showing an increase from the $376.4 million reported for the third quarter of fiscal year 2024. The company's net income for the third quarter of fiscal year 2025 was $26.0 million, a significant rise from the $8.6 million net income reported for the third quarter of fiscal year 2024. However, the consolidated adjusted EBITDA for the third quarter of fiscal year 2025 was $37.7 million, down from the $46.6 million recorded for the third quarter of fiscal year 2024.

In the Senior segment, revenue declined by 17% to $169.4 million compared to $204.3 million in the same period last year. The adjusted EBITDA for the Senior segment also dropped by 26% to $45.7 million from $61.5 million in the third quarter of fiscal year 2024. Additionally, submitted policies for Medicare Advantage decreased by 11%, and approved policies for the same segment dropped by 10% compared to the third quarter of fiscal year 2024.

In contrast, the Healthcare Services segment showed significant growth, with revenue increasing by 53% to $189.6 million from $124.2 million in the third quarter of fiscal year 2024. The segment's adjusted EBITDA also saw a substantial rise, reaching $6.4 million, a significant increase from the $1.6 million reported in the same period last year. Furthermore, the total number of SelectRX members increased by 41% compared to the third quarter of fiscal year 2024.

The Life segment also demonstrated positive results, with revenue growing by 13% to $45.8 million from $40.7 million in the third quarter of fiscal year 2024. The adjusted EBITDA for the segment saw a remarkable increase of 103% to $6.4 million compared to $3.1 million in the same period last year.

As a result of these announcements, the company's shares have moved -2.2% on the market, and are now trading at a price of $2.67. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.